Back
4D Molecular Therapeutics Stock Predictions
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
26
FDMT
4D Molecular Therapeutics
Last Price:
7.96
Seasonality Move:
57.95%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole4D Molecular Therapeutics Stock Forecast
- Over the next 52 weeks, 4D Molecular Therapeutics has on average historically fallen by 29.5% based on the past 3 years of stock performance.
- 4D Molecular Therapeutics has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is 4D Molecular Therapeutics Stock Undervalued?
The current 4D Molecular Therapeutics [FDMT] share price is $7.70. The Score for FDMT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal. - FDMT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will 4D Molecular Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, 4D Molecular Therapeutics has on average historically fallen by 29.5% based on the past 3 years of stock performance.
4D Molecular Therapeutics Stock Rating
Sell
26
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics overpriced?
- 4D Molecular Therapeutics has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
4D Molecular Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
4dmoleculartherapeutics.com
52-Week Data
52-Week High:
36.25
52-Week Low:
7.72
Prediction Charts
Market Cap:
400.17M
Price in USD:
7.70
Volume:
534.27K
Beta:
2.86
Technical Analysis
SMA50:
10.72
SMA100:
14.40
SMA200:
20.55
52-Wk Change:
-26.88%
Stock Predictions
-
Is 4D Molecular Therapeutics stock public?
Yes, 4D Molecular Therapeutics is a publicly traded company. -
What is the 4D Molecular Therapeutics stock quote today?
The 4D Molecular Therapeutics stock price is 7.70 USD today. -
How to buy 4D Molecular Therapeutics stock online?
You can buy 4D Molecular Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-25 | 8.27 | 8.15 | 8.45 | 8.09 |
| Oct-28 | 8.20 | 8.57 | 8.68 | 8.20 |
| Oct-29 | 8.47 | 8.20 | 8.62 | 8.13 |
| Oct-30 | 8.20 | 8.27 | 8.42 | 8.05 |
| Oct-31 | 8.22 | 8.01 | 8.30 | 7.99 |
| Nov-1 | 8.05 | 8.10 | 8.26 | 8.01 |
| Nov-4 | 8.05 | 8.18 | 8.43 | 7.98 |
| Nov-5 | 8.18 | 8.39 | 8.44 | 8.03 |
| Nov-6 | 8.66 | 8.35 | 8.74 | 8.30 |
| Nov-7 | 8.40 | 8.28 | 8.62 | 8.22 |
| Nov-8 | 8.31 | 8.12 | 8.47 | 8.07 |
| Nov-11 | 8.21 | 8.08 | 8.34 | 8.00 |
| Nov-12 | 7.98 | 7.87 | 8.12 | 7.72 |
| Nov-13 | 7.98 | 7.70 | 8.02 | 7.68 |
4D Molecular Therapeutics Earnings
4D Molecular Therapeutics Earnings Report: Per Share 4D Molecular Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
4D Molecular Therapeutics Forecast Revenue Growth
4D Molecular Therapeutics Stock Analysis: Historical quarterly revenues per share for 4D Molecular Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.49 per share.
* 4D Molecular Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.